期刊文献+

132例急性肠梗阻患者临床治疗效果观察 被引量:4

下载PDF
导出
摘要 目的研究和分析药物奥曲肽对于急性肠梗阻患者的临床治疗效果。方法选取该院收治的急性肠梗阻患者共132例,随机分成对照组和治疗组,该两组患者都进行常规的禁食和胃肠减压,并采取灌肠、补液和预防感染措施以及营养支持治疗。对于治疗组患者另外运用药物奥曲肽,直到梗阻解除,仔细观察观察两组患者的症状体征缓解状况和胃肠减压量以及恢复自主排气时间与治疗的有效率等指标。结果治疗组患者的临床症状缓解时间、恢复自主排气时间明显减少;24 h患者胃肠的减压量明显下降,二者比较差异有统计学意义(P<0.01);治疗组患者与对照组患者治疗有效率分别是84.6%与65.7%,二者比较差异无统计学意义(P>0.05)。结论对于急性肠梗阻患者,在常规治疗过程中另外运用奥曲肽,能够有效地缓解患者的各种临床症状,并促进肠道功能的快速恢复。
作者 郭玉香
出处 《中外医疗》 2013年第28期119-119,121,共2页 China & Foreign Medical Treatment
  • 相关文献

参考文献7

二级参考文献35

  • 1龚剑峰,朱维铭,李宁,黎介寿.营养支持在术后早期炎性肠梗阻治疗中的应用[J].腹部外科,2004,17(4):209-211. 被引量:90
  • 2彭宝岗,梁力建,胡文杰,王捷,黄敏菁,郑凯,张卓军,李威,温思奇.生长抑素治疗肠梗阻的临床研究[J].中华胃肠外科杂志,2004,7(6):474-476. 被引量:72
  • 3李幼生,黎介寿.再论术后早期炎性肠梗阻[J].中国实用外科杂志,2006,26(1):38-39. 被引量:542
  • 4Bounous G, Hampson LG, Gurd FN. Cellular nucleotieds in hemorrhagic shock. Relationship of intestinal metabolic changes to hemorrhagic enteritis and burrier function of the intestinal mucosa. Ann Surg, 1964,160:650-666. 被引量:1
  • 5Bounous G, Brown RA, Molder DS, et al. Ablation of tryptic enteritis in shocked dog. Arch Surg, 1965,91:371-375. 被引量:1
  • 6Deitch EA, Bridges WM, MA JW, et al. Obstructed intestine as a reservoir for systemic infection. Am J Surg, 1990, 159: 394-401. 被引量:1
  • 7Yamaner S, Bugra D, Muslumanoglu M, et al. Effects of octreotide in healing of intestinal anastomosis following small bowel obstruction on rats. Dis Colon Rectum, 1995,38:308-312. 被引量:1
  • 8Aldemir M, Kokoglu OF, Geyik MF, et al. Effects of octreotide acetate and Saccharomyces boulardii on bacterial translocation in an experimental intestinal loop obstruction model of rats. Tohoku J Exp Med, 2002,198 : 1-9. 被引量:1
  • 9Walsh KA. Trypsinogens and trypsins of various species. Methods Enzymol, 1970, 19:41-43. 被引量:1
  • 10Chiu CJ,McArdle AH,Brown R,et al. Intestinal mucosal lesion in low-flow states. Arch Surg, 1970,101:478-483. 被引量:1

共引文献41

同被引文献36

  • 1陈智,姚元章,屈纪富,丁茂乾,刘辉均.不同手术时机治疗急性肠梗阻的临床疗效观察[J].中国急救医学,2017,37(A01):23-25. 被引量:6
  • 2陆玉姬.急性肠梗阻诊治体会[J].云南医药,2013,34(4):314-315. 被引量:1
  • 3周文波,袁房均,戴宗晴.奥曲肽在急性肠梗阻治疗中的应用[J].中国现代普通外科进展,2005,8(3):190-190. 被引量:8
  • 4JM Pedrajas,AM Molino. Management of preventing recurrent bleed- ing angiodysplasia of the intestinal tract with octreotide [ J ]. Eur J Int Med ,2013,24 : e78 - e79. 被引量:1
  • 5Mercadante S,Porzio G. Octreotide for malignant bowel obstruction: twenty years after[ J]. Crit Rev Oncol Hematol,2012,83 (3) :388. 被引量:1
  • 6Ahit G,Patel H,Morinville VD. Oetreotide management of intestinal lymphangieetasia in a teenage heart transplant patient [ J ]. J Pediatr Gastroenterol Nutr,2012,54 (6) : 824 - 827. 被引量:1
  • 7Fuccio L, Guido A, Andreyev HJ. Management of intestinal compli- cations in patients with pelvic radiation disease [ J ]. Clini Gastroen- terol Hepatol,2012,10 (12) : 1326 - 1334. 被引量:1
  • 8Laval G, Rousselot H, Toussaint-Martel S, et al. SALTO: a random- ized,muhieenter study assessing oetreotide LAR in inoperable bowel obstruction[ J]. Bull Cancer,2012,99 (2) : E1 - 9. 被引量:1
  • 9Watari H, Hosaka M, Wakui Y, et al. A prospective study on the effi- cacy of octreotide in the management of malignant bowel obstruction in gynecologic eaneer [ J ]. Int J Gynecol Cancer, 2012,22 ( 4 ) : 692. 被引量:1
  • 10Onal C, Kayaselcuk F, Topkan E, et al. Protective effects of melato- nin and octreotide against radiation-induced intestinal injury [ J ]. Dig Dis Sci,2011,56(2) :359 -367. 被引量:1

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部